Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) issued this Form 8-K on September 9, 2014, to disclose expected communications with securities analysts and investors during a period from September 9 to September 30, 2014. The primary focus of these communications is the reaffirmation of the company's full-year 2014 net income guidance. Management anticipates reporting net income greater than $8.61 per share for the full year. This guidance includes certain adjustments. Specifically, it accounts for net favorable items totaling $0.21 per share recognized in the first two quarters of 2014. Additionally, it factors in an after-tax charge not exceeding $0.20 per share, stemming from a debt refinancing initiated in August 2014. Excluding these specific items, the company continues to project adjusted net income to be greater than $8.60 per share. The guidance explicitly excludes any investment gains or losses beyond those already recorded in the first half of 2014.
Key Highlights
- 1WellPoint, Inc. (now Elevance Health) reaffirmed its full-year 2014 net income guidance of greater than $8.61 per share.
- 2The guidance includes net favorable items of $0.21 per share recognized in the first two quarters of 2014.
- 3An after-tax charge not exceeding $0.20 per share is factored in, related to debt refinancing initiated in August 2014.
- 4Excluding these items, the company expects adjusted net income to be greater than $8.60 per share.
- 5The guidance explicitly excludes any investment gains or losses beyond those recorded in the first six months of 2014.
- 6The company is engaging in meetings with securities analysts and investors from September 9 to September 30, 2014, to discuss these financial projections.
- 7The filing includes a comprehensive Safe Harbor statement under the Private Securities Litigation Reform Act of 1995, outlining risks and uncertainties.